SCHEMBL6565629

SCHEMBL6565629

Cc1ccc(NC(=O)NCCc2ccccc2)c(O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.62
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
KMT2A Q03164 4/20 0.57
POLB P06746 1/20 0.57
MEN1 O00255 2/20 0.56
ALDH1A1 P00352 3/20 0.55
LMNA P02545 1/20 0.55
ALOX12 P18054 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GAA P10253 1/20 0.55
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
TRPV1 Q8NER1 1/20 0.54
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354544 0.86 TRPV1 (0.67) CA12CA1CA2CA9KMT2A
SCHEMBL6568616 0.86 CXCR2 (0.65) CXCR2CA12CA1CA2CA9
SCHEMBL6500550 0.85 KMT2A (0.56) CA12CA1CA2CA9KMT2A
SCHEMBL6836163 0.81 CXCR2 (0.57) CXCR2KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7859962 0.80 CXCR1 (0.65) CXCR2CA12CA1CA2CA9
SCHEMBL10192078 0.79 ALDH1A1 (0.83) CA12CA1CA2CA9KMT2A
SCHEMBL14224546 0.78 CXCR2 (0.60) CXCR2KMT2AMEN1L3MBTL1GAA
SCHEMBL4345348 0.78 EPHX2 (0.56) CXCR2KMT2APOLBMEN1ALDH1A1
SCHEMBL10192070 0.78 KMT2A (0.82) CA12CA1CA2CA9KMT2A
SCHEMBL5605320 0.77 CXCR2 (1.00) CXCR2KMT2AMEN1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed